Trial intelligence / Profile preview

Ondansetron for prevention of spinal anesthesia-related hypotension during elective cesarean section

IRCT20241024063488N2Phase 2Completed

Sponsor
Vice Chancellor for Research, Birjand University of Medical Sciences
Start
Apr 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in hypotension comparing Ondansetron with Placebo control (2 arms). Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 8 more. Started Apr 2025; status: completed.

02

Drugs

ondansetron
03

Conditions

hypotension

Beyond the preview

Go deeper on IRCT20241024063488N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20241024063488N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call